Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX)
CAPS Rating:
A biopharmaceutical company focused on the discovery and development of breakthrough treatments for human disease.
The World's Greatest Investing Community
A biopharmaceutical company focused on the discovery and development of breakthrough treatments for human disease.
BATS data provided in real-time. NYSE, NASDAQ and NYSEMKT data delayed 15 minutes.
Real-Time prices provided by BATS. Market data provided by Interactive Data.
Company fundamental data provided by Morningstar. Earnings Estimates, Analyst Ratings and Key Statistics provided by Zacks.
SEC Filings and Insider Transactions provided by Edgar Online.
Powered and implemented by Interactive Data Managed Solutions. Terms & Conditions
RSS Headlines
Fool UK
Recs
A small company that gets very little attention, working in apparently random areas like bowel issues and rheumatiod arthritis. Diabetes, however, is a research zone where they've suddenly picked up and, with a current price slip, insiders and board members are accumulating shares hand over fist. Speculative, but promising.